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Dentate gyrusDavid De Wied had a fundamental interest in the brain and behaviour, with a particular interest in the
interface between cognition and emotion, and how impairments at this interface could underlie human
psychopathology. The NMDA subtype of glutamate receptor is an important mediator of synaptic plasticity
and plays a central role in the neurobiological mechanisms of emotionality, as well as learning and memory.
NMDA receptor antagonists affect various aspects of emotionality including fear, anxiety and depression, as
well as impairing certain forms of learning and memory. The hippocampus is a key brain structure,
implicated in both cognition and emotion. Lesion studies in animals have suggested that dorsal and ventral
sub-regions of the hippocampus are differentially involved in dissociable aspects of hippocampus-dependent
behaviour. Cytotoxic lesions of the dorsal hippocampus (septal pole) in rodents impair spatial learning but
have no effect on anxiety, whereas ventral hippocampal lesions reduce anxiety but are without effect on
spatial memory. This role for the ventral hippocampus in anxiety is distinct from the role of the amygdala in
other aspects of emotional processing, such as fear conditioning. Recent studies with genetically modiﬁed
mice have shown that NR1 NMDA receptor subunit deletion, speciﬁcally from the granule cells of the dentate
gyrus, not only impairs short-term spatial memory but also reduces anxiety. This suggests that NMDA
receptors in ventral hippocampus may be a key locus supporting the anxiolytic effects of NMDA receptor
antagonists. These data support Gray's neuropsychological account of hippocampal function.: +44 1865 310447.
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The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor
is an important mediator of synaptic plasticity, reﬂecting (i) its dual
ligand and voltage gating, (ii) its calcium conductance and (iii) the
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NMDA receptor antagonists prevent the induction of certain forms of
long-term potentiation, long-term depression and depotentiation
(Collingridge et al., 1983; Dudek and Bear, 1992; Fujii et al., 1991;
Mulkey and Malenka, 1992). The NMDA receptor also plays a central
role in both emotionality and cognition. NMDA receptor antagonists
affect various aspects of emotionality including fear, anxiety and de-
pression, as well as impairing certain forms of learning and memory.
Brain structures in themedial temporal lobe, such as the hippocampus
and amygdala, lie at the interface between cognition and emotion, and
are likely candidate sites at which NMDA receptor antagonists might
exert their effects on emotionality. In particular, NMDA receptors in
the hippocampus may be the key locus for the anxiolytic effects of
these drugs. In this article we will ﬁrst review the effects of NMDA
receptor antagonists on anxiety. We will then review the evidence,
both from lesion studies in animals and from human brain imaging,
suggesting that the hippocampus (and in particular the ventral hip-
pocampus) and amygdala make dissociable contributions to anxiety
and fear respectively. Finally, we will discuss recent evidence from
genetically modiﬁed mice which speciﬁcally implicates NMDA recep-
tors in the hippocampus in anxiety.
2. NMDA receptor antagonists and emotionality
There is now an extensive literature describing the effects of NMDA
receptor antagonists on emotional processing in rodents. Broadly
speaking, these studies have often been divided along the lines of
tests of either (i) unconditioned anxiety, or (ii) conditioned fear,
although, as we shall discuss later in this article, this distinction may be
over-simplistic. Nevertheless, for the purposes of brieﬂy reviewing the
literature onNMDAreceptor antagonistswewill keep to this distinction,
and we will focus primarily on tests of unconditioned anxiety.
2.1. NMDA receptor antagonists and unconditioned anxiety
A number of different classes of NMDA receptor antagonists, acting
at different sites on the NMDA receptor complex, have been assessed
using unconditioned tests of anxiety in rodents. For example, several
competitive NMDA receptor antagonists have been shown to exhibit
anxiolytic effects in various different laboratory tests of anxiety. For
example, 3-(2-carboxy piperazine-4yl)-propyl-1-phosphonic-acid,
(CPP) increased the amount of time spent in the open arms of the
elevated plus maze and increased social interaction in rats, consistent
with a reduction in anxiety (Corbett and Dunn, 1993; Dunn et al.,
1989). Dunn et al. (1989) also investigated the effects of two related
competitive antagonists, AP5 (2-amino-5-phosphonoheptanoate)
and AP7 (2-amino-7-phosphonoheptanoate), with both compounds
producing anxiolytic effects on the elevated plus maze and increased
social interaction. Subsequent studies showed that intracerebroven-
tricular (i.c.v.) injections of AP7 in rats were also effective in reducing
anxiety on the elevated plus maze (Plaznik et al., 1994).
Possibly the best characterised of all of the NMDA receptor antag-
onists in the laboratory is the non-competitive channel blocker, MK-
801 (dizocilpine), which is an effective anxiolytic in conﬂict intake
studies (Corbett and Dunn, 1993; Jessa et al., 1996; Plaznik et al.,
1994; Soderpalm et al., 1995; Xie and Commissaris, 1992), on the
elevated plus maze (Bertoglio and Carobrez, 2003; Corbett and Dunn,
1991, 1993; Criswell et al., 1994; Dunn et al., 1989; Engin et al., 2009;
Fraser et al., 1996; Karcz-Kubicha et al., 1997; Plaznik et al., 1994;
Wieronska et al., 2003), and in tests of social interaction in the rat
(Corbett and Dunn, 1991, 1993; Dunn et al., 1989). Other non-com-
petitive NMDA receptor antagonists have also exhibited anxiolytic
effects in rodents. For example, phencyclidine (PCP) reduces anxiety
in rat conﬂict intake studies (Porter et al., 1989) and on the elevated
plusmaze inmice (Wiley et al., 1995). Surprisingly, ketamine, another
widely studied non-competitive NMDA receptor antagonist, producedanxiogenic effects in rats. Ketamine decreased time spent in the open
arms of the elevated plus maze and decreased social interaction
(Silvestre et al., 1997, but see also Engin et al., 2009). This effect on the
elevated plus maze was also seen following chronic (35 day) oral
voluntary consumption (Silvestre et al., 2002), but not when testing
weeks after ﬁve daily injections of 30 mg/kg i.p (Becker et al., 2003). In
contrast, ketamine has been shown to be an anxiolytic on the elevated
plus maze in mice (Hayase et al., 2006). Therefore, the animal data on
ketamine is contradictory and is complicated by the possibility that the
drugmight exert some of its effects through other receptor classes (see
for instance Abelson et al., 2006; Chen et al., 2009; Hevers et al., 2008;
Hirota and Lambert, 1996; Hirota et al., 1999; Kapur and Seeman, 2002;
Maeng et al., 2008; Okamoto et al., 2003). Interestingly, at doses as
low as 0.1 mg/kg i.v., ketamine reduces anxiety in healthy human vol-
unteers (Krystal et al., 1994), consistent with the anxiolytic proﬁle
displayed by other competitive and non-competitive NMDA receptor
antagonists in rodents.
Antagonists acting at the glycine site on the NMDA receptor
complex also produce anxiolytic effects in rodents, These include
7-chlorokynurenic acid (7 CKA, Anthony and Nevins, 1993; Trullas
et al., 1989), 5,7-dichlorokynurenic acid (5,7 DCKA, Corbett and Dunn,
1993; Kehne et al., 1991; Plaznik et al., 1994) and L-701,324 (Karcz-
Kubicha et al., 1997; Kotlinska and Liljequist, 1998; Przegalinski et al.,
1998). In addition, ifenprodil, an antagonist acting at the polyamine
site on the NR2B subunit, has also been shown to reduce anxiety on the
elevated plus maze in mice (Fraser et al., 1996). These results demon-
strate that other modulatory sites on the NMDA receptor complex may
be targeted to alter anxiety in addition to direct antagonism of the
NMDA pore region or the glutamate binding site.
Thus, there is considerable evidence that NMDA receptor antago-
nists, acting at a number of different sites on the receptor complex,
can reduce anxiety, both in humans and experimental animals. But
where do these drugs act to produce their anxiolytic effects, and what
are the neurobiological mechanisms involved? The majority of drug
studies have involved systemic administration and so it is difﬁcult to
establish the locus of effect, and to attribute changes in behaviour to a
particular mechanism. Recent advances in transgenic mouse technol-
ogy have allowed speciﬁc receptor subunits to be targeted in speciﬁc
brain regions. We recently studied the behaviour of genetically
modiﬁed mice in which the NR1 subunit of the NMDA receptor was
deleted speciﬁcally from the granule cells of the dentate gyrus and
found evidence for a role for hippocampal NMDA receptors in both
learning and anxiety (Niewoehner et al., 2007). Before describing the
behavioural phenotype in these animals it is ﬁrst worth discussing
why the hippocampus is considered an important brain area in
emotionality, and, in particular, for anxiety.
3. The hippocampus and behaviour
The predominant view in neuroscience is that the hippocampus is
involved in memory. This stems originally from studies of human
amnesics with hippocampal damage, such as H.M. (Scoville andMilner,
1957), and since this memory loss in human patients was ﬁrst de-
scribed, numerous mnemonic theories of hippocampal function have
been put forward, and have dominated the ﬁeld of hippocampal
research. Rodents with complete hippocampal lesions are dramatically
impaired on tests of spatial learning such as the Morris watermaze
task (Deacon et al., 2002a; Morris et al., 1982, 1990), but hippocampal
lesions also produce clear effects on certain non-spatial memory tasks,
particularly when there is a temporal component (Fortin et al., 2002;
Kesner et al., 2002; Mariano et al., 2009; Meck et al., 1984).
However, in recent years there has been an increasing interest in
the role of the hippocampus in emotionality. If one types “hippocam-
pus” into PubMed along with various other keys words (as of May,
2009), then, not surprisingly, there are an enormous number of
papers concerning “memory” (13,755). But there is also huge interest
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“hippocampus” and “emotion” gets over 2000 hits, “hippocampus”
and “anxiety” gets 1600 hits, “hippocampus” and “depression” gets
nearly 5000 hits, and “hippocampus” and “stress” identiﬁes over 5000
papers. So there is a signiﬁcant interest in the role of the hippocampus
in emotion and this has came to the fore in recent years with the
suggestion that anti-depressant drugs might produce their clinical
effects on emotion by increasing the production of new neurons in the
dentate gyrus subﬁeld of the hippocampus (Santarelli et al., 2003).
Although the precise relationship between hippocampal neurogenesis
and emotionality remains unclear, and more recent studies have
failed to substantiate fully the requirement for hippocampal neuro-
genesis in anti-depressant drug action (David et al., 2009; Holick et al.,
2008; Huang et al., 2008), these studies nevertheless highlight a
growing interest in the hippocampus in aspects of emotion, and, in
particular, in anxiety and depression. Importantly, hippocampal
lesions also reduce anxiety on a variety of laboratory tests (Deacon
et al., 2002b; Gray, 1982; Gray and McNaughton, 1983; Gray and
McNaughton, 2000).
Thus, the hippocampus is important not only in certain kinds of
memory, but also for aspects of emotional processing, and this poten-
tial diversity of function is illustrated by the range of behavioural
effects that are observed after hippocampal lesions in rodents. In recent
years it has become clear that these different effects of hippocampal
lesions involve different sub-regions of the hippocampus.
3.1. Dorsal hippocampal lesions impair spatial learning
The introduction and widespread deployment of cytotoxic ﬁbre-
sparing lesions was a key development because it allowed the con-
tributions of the different sub-regions within the hippocampus to
different aspects of hippocampus-dependent behaviour to be identi-
ﬁed. Cytotoxic lesions, made by injecting glutamate analogues such as
NMDA or ibotenic acid, destroy the cells in the region of interest but
spare overlying tissue, ﬁbres of passage and blood vessels in that area
(Jarrard, 1989). They therefore allow the experimenter to selectively
lesion one hippocampal sub-region without affecting the other. In a
series of experiments we compared the behavioural effects of hip-
pocampal lesions, comprising either the dorsal 50% (i.e. from the
septal pole, corresponding to the posterior hippocampus in primates)
or the ventral 50% (i.e. from the temporal pole, corresponding to the
anterior hippocampus in primates).
In agreement with the previous work of Moser et al. (1993, 1995),
we found that the dorsal hippocampus was essential for spatial
learning on tasks including the Morris watermaze (Bannerman et al.,
2002, 1999; McHugh et al., 2004). In contrast, ventral hippocampal
lesions were without effect on spatial memory (see also Bannerman
et al. (2003). For example, the standard version of the watermaze task
involves training rodents to ﬁnd a hidden escape platform that
remains in a ﬁxed location on every trial (Morris et al., 1982). The rat
is released from various different starting points around the perimeter
of the maze and has to use the extramaze spatial cues located around
the room to ﬁnd the platform. Rodents with complete or dorsal hip-
pocampal lesions had longer latencies and travelled greater distances
to ﬁnd the platform during training compared to sham operated
control animals (Bannerman et al., 1999). Furthermore, when a probe
test was conducted, during which the platformwas removed from the
pool, controls spent most of their time searching in the area of the
pool where the platform was located, whereas rats with complete
or dorsal hippocampal lesions showed no such preference for the
training quadrant. In contrast, the ventral hippocampal lesioned rats
were indistinguishable from controls, both during training and the
probe test.
This dissociation between the effects of dorsal and ventral hippo-
campal lesions has also been observed on other spatial memory tasks,
including the spatial working memory, T-maze rewarded alternationtask (Bannerman et al., 2003, 1999; Hock and Bunsey, 1998) and
the radial maze (Pothuizen et al., 2004). Interestingly, there are
parallels in the human literature. Famously, it has been shown that
London taxi drivers, a subset of the population that are continuously
engaged in complex spatial navigation as part of their daily work,
possess enlarged hippocampi compared to age-matched controls,
and this increase is speciﬁc to the posterior hippocampus (the
primate equivalent of the rodent dorsal hippocampus, Maguire et al.,
2000).3.2. Ventral hippocampal lesions reduce conditioned freezing
So what does the ventral hippocampus do? The nature of the
anatomical connections to and from the ventral hippocampus may
provide a clue to its function. The ventral sub-region differs markedly
from the dorsal sub-region in its anatomical connections (for reviews
see Dolorfo and Amaral, 1998; Krettek and Price, 1977; Moser and
Moser, 1998). It projects to the prefrontal cortex and is closely con-
nected to the bed nucleus of the stria terminalis (BNST) and the
amygdala, as well as other sub-cortical structures which are associ-
ated with the hypothalamic-pituitary-adrenal (HPA) axis. This strong
connectivity between ventral hippocampus and both the hypothala-
mus and the amygdala, made it tempting to propose a role for the
ventral sub-region in aspects of emotionality.
Emotional processing is widely studied using simple, Pavlovian
fear conditioning procedures. A neutral, discrete stimulus such as a
tone (the conditioned stimulus; CS) is paired with a motivationally
signiﬁcant stimulus, usually a footshock (the unconditioned stimulus;
US). After several CS–US pairings, presentation of the tone CS evokes
an increase in freezing (the conditioned response; CR), in the absence
of any footshock, suggesting that the animal has learned an associ-
ation between the two stimuli (Bouton and Bolles, 1979). In addition,
the animal also learns to associate the experimental context with the
footshock and is therefore likely to freeze on being returned to the
operant chamber in which the conditioning took place, in the absence
of any other stimuli.
The neurobiology of fear conditioning has been studied exten-
sively and the importance of the amygdala for fear conditioning is well
established, both from lesion studies in animals (for example Phillips
and LeDoux, 1992), and from human imaging studies (for example
Buchel et al., 1998; Hasler et al., 2007; LaBar et al., 1998). In addition,
hippocampal lesions can also disrupt conditioned freezing, although it
has often been reported that the deﬁcits in freezing are speciﬁc to the
experimental context and do not occur with punctate CS cues, such as
a light or tone (Kim and Fanselow, 1992; Phillips and LeDoux, 1992)
(but see also (Good and Honey, 1997).
Consistent with a preferential role for ventral hippocampus in
emotionality, we found deﬁcits in conditioned freezing in ventral, but
not dorsal, hippocampal lesioned rats (Bannerman et al., 2003;Maren,
1999; Maren et al., 1997; Richmond et al., 1999). In our study, ventral
hippocampal lesioned rats, and rats with complete hippocampal
lesions, exhibited reduced freezing responses relative to sham-oper-
ated controls immediately after the delivery of footshocks during the
conditioning session, and also during a subsequent extinction session
when animals were returned to the experimental context in the
absence of further shocks (Richmond et al., 1999). In addition, we also
saw reduced freezing to the tone CS, presented in a separate, novel
context, in both ventral and complete lesion groups, suggesting that
the deﬁcits in conditioned freezing are not always speciﬁc to freezing
induced by the experimental context. Importantly, these results
provided a double dissociation between the effects of ventral hip-
pocampal damage on conditioned freezing and the effects of dorsal
hippocampal lesions on spatial learning, thus supporting a speciﬁc
role for the ventral sub-region of the hippocampus in emotionality
(Bannerman et al., 2004).
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Neuropsychological accounts of the role of the hippocampus in
emotionality have emphasized its importance for anxiety (Gray, 1982;
Gray and McNaughton, 2000). Furthermore, these accounts suggest
that anxiety is the emotional response that arises in situations of
conﬂict and uncertainty. An obvious source of conﬂict or uncertainty
arises when there is a mismatch between what is expected on the
basis of information retrieved from memory and what actually hap-
pens. Human neuroimaging studies have implicated the hippocampal
formation in the detection of mismatches between expected and
actual experience during fear conditioning. Ploghaus et al. (2000)
used fMRI to study brain activation using a fear conditioning paradigm
in which different coloured lights were associated with either no
stimulation, delivery of a non-noxious warm stimulus or a painful
heat stimulus applied to the back of the hand. Activation of the
hippocampal formation (hippocampus and parahippocampal gyrus/
entorhinal cortex) was associated with three different situations
during the fear conditioning paradigm, (i) novel, unexpected pain
when subjects had no prior knowledge and hence no expectation as
to which visual stimulus was paired with pain, (ii) unexpected omis-
sion of pain when the expected painful stimulus was absent during
extinction, and (iii) counter-expected pain when the painful stimulus
was now delivered when no stimulus was expected (i.e. the painful
stimulus was delivered unexpectedly during a signalled rest or safe-
ty period indicated by a different background contextual cue). There-
fore, hippocampal activation was associated with both unexpected
delivery and unexpected omission of painful stimuli.
More recently, hippocampal activation has also been observed
during mismatch detection in human fMRI studies, using non-
aversive paradigms (Kumaran and Maguire, 2006, 2007). In parallel,
hippocampal lesioned rats failed to detect mismatches that were
generated when an auditory stimulus that had been speciﬁcally
associated with one visual stimulus was presented with a different,
but equally familiar, visual stimulus using a non-aversive testing
paradigm (Honey et al., 1998). Rats were trained with two audio–
visual sequences. In the ﬁrst sequence a tone was always followed by
a constant light whereas for the second sequence a clicker was always
followed by a ﬂashing light. Both sham and hippocampal lesioned
animals habituated to the visual stimuli as training continued. On a
test trial, the auditory stimuli preceding the visual target stimuli were
switched (i.e. clicker-constant light and tone-ﬂashing light). This
resulted in renewed orienting responses to the visual stimuli in the
control subjects, suggesting that they had detected the associative
mismatch, but this was not the case in the hippocampal lesioned
animals.
In a recent human PET imaging study, brain activation was studied
in anticipation of electric shocks that were either predicted by a visual
cue or delivered unpredictably and thus associated with the back-
ground context (Hasler et al., 2007). Anterior (i.e. ventral) hippo-
campal activation was associated with the unpredictable, contextual
threat condition. Of course, this hippocampal activity could reﬂect a
role in processing contextual information (Hirsh, 1974), but it could
also reﬂect the increased uncertainty associated with the context
as a predictor of shock. The importance of uncertainty in generating
anxiety and hippocampal activation has been demonstrated in a study
by Ploghaus et al. (2001) in which they studied the exacerbation of
pain by anxiety. A visual stimulus (V1) was associated with a mod-
erate intensity, painful stimulus on all trials and thus generated low
anxiety. A second visual stimulus (V2) was paired with a moderate
pain stimulus on the majority of trials, but on a small number of trials
preceded the delivery of a high intensity painful stimulus. This re-
sulted in a high anxiety condition, with subjects reporting feelings of
high anxiety on presentation of V2, prior to the delivery of the painful
US. V2 also produced a larger response to the moderately painful
stimulus in terms of pain ratings (anxiety-induced hyperalgesia), andincreased neuronal activity in an area of the parahippocampal gyrus,
corresponding to the entorhinal cortex. Thus, the anxiety induced by
uncertainty can also result as a consequence of an unpredictable
association between a punctate visual CS and the magnitude of an
aversive US.
The importance of uncertainty in generating hippocampus-
dependent anxiety may explain why hippocampal lesion studies in
rodents have often found what appear to be speciﬁc deﬁcits in
contextual fear conditioning, with no effect on conditioned freezing to
punctate auditory or visual cues. By its very nature, the context is
going to be a relatively poor predictor of the delivery of the footshock
(i.e. for the vast majority of the time that the animal is experiencing
the experimental context it is not receiving shock). In contrast, there
is usually an absolute relationship between the tone or the light CS
and the delivery of the footshock, making the punctate cue a perfect
predictor of shock. Therefore, the context will generate much greater
uncertainty in terms of its ability to predict the occurrence of the
shock.
3.4. Hippocampal lesions and unconditioned tests of anxiety
There is considerable additional evidence from lesion studies in
rodents that the hippocampus is important for anxiety. Hippocampal
lesions and, speciﬁcally ventral hippocampal lesions, have robust
effects on ethologically based, unconditioned laboratory tests of anxiety
which generate an approach/avoidance conﬂict. Indeed, the approach/
avoidance conﬂict provides the basis for the majority of laboratory
anxiety tests. For example, the elevated plusmaze, considered bymany
as the industry standard test of anxiety, generates a conﬂict between
two concurrent goals that can potentially drive the behaviour of the
animal. The animal has an exploratory drive to investigate the open
arms of the elevated plusmaze. Therefore, there is a potential approach
response towards the open arms. Against this, the open arms are
exposed and potentially dangerous (compared to the closed arms).
Therefore, there is also a potential avoidance response towards the
open arms. These concurrent approach and avoidance responses gen-
erate anxiety. Hippocampal lesioned animals display reduced anxiety
and increased approach behaviour on simple, ethological, uncondi-
tioned tests like the elevated plus maze (Bannerman et al., 2002, 2003;
Kjelstrup et al., 2002; McHugh et al., 2004, see also Chudasama et al.,
2008). In this regard, the behavioural effects of hippocampal lesions
closely resemble the effects of anxiolytic drugs such as benzodiaz-
epines which also increase approach behaviour (Gray, 1982; Gray and
McNaughton, 1983, 2000).
For example, we assessed anxiety in groups of lesioned rats using
the successive alleys test, which is a modiﬁed form of the elevated
plus maze. The apparatus consists of four sections or alleys of in-
creasing anxiogenic character in a linear arrangement (Fig. 1). The
ﬁrst section is fully enclosed with high walls and is painted black. By
gradually reducing the height of the side walls and the width of the
arms, and by increasing the brightness, Sections 2, 3 and 4 provide
increasingly anxiogenic stimuli. The more anxious an animal, the
more time it will spend in the enclosed arms, and the less time it will
spend in the more open, exposed (and potentially dangerous) arms.
The fact that there are 4 arms of differing anxiogenic character in a
linear arrangement is designed to make the test more sensitive by
providing a range of anxiogenic conditions. This arrangement also
avoids the interpretational difﬁculties associated with the central
square of the elevated plus maze. Animals were placed in the appa-
ratus for 5 min and the times spent in each of the 4 sections were
measured. Rats with dorsal or ventral hippocampal lesions, and
amygdala lesioned animals were compared to sham-operated con-
trols (McHugh et al., 2004). Whereas sham rats, rats with dorsal
hippocampal lesions, and rats with amygdala lesions spent most of
their time in the least anxiogenic arm, (Section 1), the animals with
ventral hippocampal lesions spent comparatively more time in the
Fig. 1. NMDA receptors in the ventral hippocampus mediate anxiety. (a) The successive
alleys test of anxiety is a modiﬁed version of the elevated plus maze. The apparatus
consists of four sections or alleys of increasing anxiogenic character in a linear
arrangement. (b) The effects of sham, dorsal hippocampal (dHPC), ventral hippocampal
(vHPC) and amygdala lesions on the successive alleys test in rats. vHPC lesioned rats
were less anxious than all of the other three groups (e.g. time in Alley 2; F (3,47)=4.0;
P<0.05, Duncan's pairwise comparisons at P<0.05), (from McHugh et al., 2004). (c) In
situ hybridisation of littermate control animals (left) and DG speciﬁc NR1 deleted mice
(NR1ΔDG) (right) with NR1 speciﬁc probe. The lower panels give a zoom of the hip-
pocampus from the respective upper panels (scale bars: 1 mm). (d) The effect of NR1
NMDA receptor subunit deletion from granule cells of the dentate gyrus on the suc-
cessive alleys test in mice. NR1ΔDG mice were less anxious than wild-type littermate
controls, spending comparatively more time in the more anxiogenic alleys (genoty-
pe×alley interaction — F (2,66)=3.4; P<0.05, simple main effects; Alley 2 — F (1,88)=
4.1; P<0.05, Alley 3 — F (1,88)=4.0; P=0.05) (from Niewoehner et al., 2007;
Supplementary material).
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effects observed when normal rats were given a 2.5 mg/kg dose of
chlordiazepoxide. Thus, animals with ventral hippocampal lesions
showed reduced anxiety.
The same pattern of results was also observed on a variety of other
anxiety tests, including the food neophobia (hyperneophagia) task
and a social interaction task. Ventral hippocampal lesioned animals
were faster to eat a novel foodstuff in a novel, potentially dangerous,
environment (Bannerman et al., 2002; McHugh et al., 2004). They also
displayed increased levels of social interaction compared to othergroups when placed with an unfamiliar animal. In each case the
ventral lesioned animals demonstrated behaviour consistent with a
reduction in anxiety, resembling the effects seenwith benzodiazepines.
Importantly, the effects of ventral hippocampal lesions were dis-
sociable, not only from the effects of dorsal hippocampal lesions on
spatial memory, but also from the effects of amygdala lesions. Notably,
amygdala lesions did not affect performance on the successive alleys
test (McHugh et al., 2004), and others have previously shown that
amygdala lesions are also without effect on the elevated plus maze
(Kjelstrup et al., 2002; Treit and Menard, 1997). They do, however,
reliably impair fear conditioning (for example Phillips and LeDoux,
1992). This dissociation supports the idea that anxiety and fear are
separate psychological constructs involving the hippocampus and
amygdala respectively.
4. Fear versus anxiety
As previously suggested, anxiety arises when there is a conﬂict
between potential response options available to the animal. In labo-
ratory tests of anxiety, like the elevated plus maze or the successive
alleys test, this manifests as an approach/avoidance conﬂict with
respect to exploration of the open arms. It has been suggested that the
distinction between fear and anxiety is best encapsulated by the
concept of defensive direction (Gray andMcNaughton, 2000). Where-
as fear is a behavioural state that functions to remove the animal from
a dangerous situation (active avoidance), or to deal with that dan-
gerous situation by adopting the appropriate stimulus-speciﬁc
response in the presence of a stimulus that has become associated
with danger (such as freezing in response to a cue associated with
footshock), anxiety functions to limit whether or not the animal
should enter into a potentially dangerous situation (passive avoid-
ance). In other words, fear is the response to a threat that is present,
whereas anxiety is the response to a potential threat. These different
behavioural responses to present or potential danger differentially
depend on the amygdala and ventral hippocampus respectively, and
exist within a hierarchical defense system that is arranged to protect
the animal from harm.
Gray has suggested that the septo-hippocampal formation is the
seat of anxiety in the brain, and that it acts, ﬁrst, to detect situations of
conﬂict or uncertainty, and then second, to resolve those conﬂicts and
thus protect the animal from danger (and/or maximize its chances of
reward; see Gray and McNaughton, 2000). It has long been suggested
that the hippocampal formation could potentially act as a comparator,
allowing novel or unexpected events to be detected by comparing the
current state of the world with what would be expected on the basis
of information retrieved from memory, and thus allow situations of
conﬂict to be identiﬁed (Gray, 1982; Gray and McNaughton, 2000;
Vinogradova, 1975). Having detected a conﬂict (a novel or unexpect-
ed event), the hippocampal formation acts to resolve the conﬂict by
increasing levels of attention and arousal, and through behavioural
inhibition of prior, on-going motor programs. These behavioural
responses constitute anxiety and they allow the animal to gather
more information in order to resolve the conﬂict before responding
appropriately. Mechanistically, Gray and MacNaughton suggested that
the hippocampal system resolves the conﬂict by increasing the
weighting given to affectively negative information. In other words, in
a normal animal the hippocampal system will act to favour avoidance
behaviour over approach behaviour.
5. Hippocampal NMDA receptors and anxiety
It is therefore tempting to suggest that the anxiolytic effects of
NMDA receptor antagonists reﬂect the blockade of NMDA receptors in
the hippocampus, and, in particular, in the ventral hippocampus.
Indeed, there is now evidence from a variety of sources to suggest
that this is the case. For example, it is now possible to assess the
54 C. Barkus et al. / European Journal of Pharmacology 626 (2010) 49–56importance of hippocampal NMDA receptors for anxiety using ge-
netically modiﬁed mice in which particular receptor subunits can be
speciﬁcally deleted from spatially restricted hippocampal subﬁelds.
Using this approachwe recently assessed the behaviour of mice that
lack theNR1 subunit of theNMDAreceptor exclusively from the granule
cells in the dentate gyrus subﬁeld of the hippocampus (Niewoehner
et al., 2007, see also Fig. 1). In terms of electrophysiology, these mice
exhibited normal LTP in the CA1 region but dramatically reduced LTP in
both the medial and lateral perforant path inputs to the dentate gyrus.
In terms of learning andmemory, the dentate gyrus NR1 knockoutmice
exhibited a very selective impairment in short-term spatial working
memory. Anxiety was assessed in these mice on a version of the suc-
cessive alleys test that was modiﬁed for mice (Niewoehner et al., 2007,
see Supplementary material). The dentate gyrus NR1 knockout mice
were found to be less anxious. They were more likely to approach and
explore the open, exposed sections of the apparatus compared to their
wild-type littermates, thus resembling rodents with ventral hippocam-
pal lesions (Fig. 1). More recently, we have also studied genetically
modiﬁed mice that lack the NR2B subunit of the NMDA receptor,
speciﬁcally from hippocampal granule and pyramidal cells in the den-
tate gyrus and CA1 subﬁelds respectively (von Engelhardt et al., 2008).
Again, these animals displayed a reduced anxiety phenotype on the
successive alleys test, being more inclined to venture out into the more
open sections of the maze compared to their wild-type littermates.
Therefore, studies with transgenic animals with hippocampal-
speciﬁc NMDA receptor subunit deletions support a key role for hip-
pocampal NMDA receptors in anxiety. However, at present these
genetically modiﬁed mice are unable to differentiate between con-
tributions from dorsal and ventral sub-regions of the hippocampus. To
resolve along these lines a pharmacological approach is required. In a
recent study, the NMDA receptor antagonist AP5 has been infused
locally into either the dorsal or ventral hippocampus of rats prior to
testing on the elevated plus maze (Nascimento Hackl and Carobrez,
2007). This study revealed an anxiolytic effect of 6 and 24 nmol AP5,
but only when infused into the ventral hippocampus. There was no
effect of the drug on measures of anxiety on the elevated plus maze
when infused into dorsal hippocampus, using either AP5 (Nascimento
Hackl and Carobrez, 2007) or the related compound AP7 (Padovan
et al., 2000). This study thus provides evidence for a role for ventral
hippocampal NMDA receptors in anxiety.
6. Conclusions
In summary, NMDA receptor antagonists exert a range of effects on
emotionality, including a reduction of anxiety. In order to establish
the neurobiological mechanisms and brain circuits that mediate these
anxiolytic effects, it is necessary ﬁrst to understand the psychological
basis of anxiety, and to recognise that it represents a separate
construct from other aspects of emotionality. Neuropsychological
theories have suggested that anxiety is an emotional response that
arises speciﬁcally in situations of conﬂict and uncertainty (Gray, 1982;
Gray and McNaughton, 2000). Brain imaging studies in humans, and
experimental lesion studies in animals, have implicated the hippo-
campus, and particularly, the ventral sub-region of the hippocampus,
in anxiety. It is therefore tempting to suggest that NMDA receptor
antagonists exert their anxiolytic effects through blockade of NMDA
receptor in ventral hippocampus. Indeed, there is now evidence, both
from studies with genetically modiﬁed mice in which NMDA receptor
subunits are deleted speciﬁcally from the hippocampus, and from
intra-hippocampal drug infusions in rats that this is the case.
The challenge now is to identify the NMDA receptor-dependent
synaptic and cellular mechanisms that might underlie anxiety, and to
establish if, and how, these same mechanisms might contribute to
spatial memory performance. The internal anatomical structure with-
in the hippocampus suggests a common algorithm being executed,
both by the dorsal hippocampus in spatial memory and the ventralhippocampus in anxiety. For example, the same repeating lamellar
structure exists along the entire dorso-ventral axis of the hippocam-
pus, characterised by the well-deﬁned tri-synaptic circuitry, through
which information ﬂows from entorhinal cortex to dentate gyrus to
CA3 to CA1. This common architecture in both sub-regions suggests a
common operation being performed in both spatial memory and
anxiety. Studies with genetically modiﬁed mice in which NMDA
receptors are selectively deleted from the different hippocampal sub-
ﬁelds are likely to be of great importance for identifying this algorithm
(or algorithms).References
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